VEID250003-GSA global fever panel - RUO, 6 tests required to be distributed among febrile surveillance study sites to help detect and identify viral pathogens causing acute febrile illness.
Ended Awarded Last action
- Contract number
- N4485225FA003
- Awardee
-
Biofire Defense LLC UEI NHMDGM122546
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $77,478
Award facts
- Contract value 100% obligated
- $77,478.40 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Peru
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $806 | |
| Original award | $76,672 |
About this award
Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a firm fixed-price delivery order by the Bureau of Medicine and Surgery (BUMED) valued at $77,478.40 on July 11, 2025. The contract calls for the delivery of GSA Global Fever Panel tests—specifically six tests to be distributed among febrile surveillance study sites in Peru. These diagnostic kits are intended to detect and identify viral pathogens causing acute febrile illness, supporting the Department of Defense's public health surveillance and biodefense capabilities. The delivery order carries an ultimate completion date of April 30, 2026, and was issued under the Multiple Award Schedule (MAS) procurement vehicle without a set-aside designation.
This award reflects BUMED's ongoing reliance on Biofire Defense for specialized infectious disease diagnostic solutions. The company has established itself as a critical federal vendor through its FilmArray and RAZOR systems and maintains substantial indefinite delivery vehicles across multiple agencies, including a $20.97 million Other Transaction agreement with the Joint Program Executive Office for Chemical and Biological Defense. The Global Fever Panel procurement aligns with the Department of Defense's broader medical readiness objectives and international health surveillance operations, leveraging Biofire Defense's proven capability to deliver rapid, accurate pathogen identification technologies in support of military medical operations and force protection.
Quick answers
Who was awarded contract N4485225FA003?
N4485225FA003 was awarded to Biofire Defense LLC by Bureau of Medicine and Surgery (Department of the Navy) on July 11, 2025.
How much is contract N4485225FA003 worth?
The government has obligated $77,478 on N4485225FA003.
Is contract N4485225FA003 an order under another contract?
Yes. N4485225FA003 is a delivery order under 47QSWA18D009D, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract N4485225FA003 competed?
The extent of competition for N4485225FA003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award